EUCLID University, a global leader in intergovernmental higher education, is thrilled to announce the appointment of Professor Basile Njei, MD, MPH, PhD, as a distinguished faculty member in its School of Global Health and Bioethics. A world-renowned expert in digestive diseases and a trailblazer in integrating genetics and artificial intelligence (AI) into medical research, Professor Njei brings a wealth of expertise from his tenure at Yale School of Medicine. His appointment underscores EUCLID’s unwavering commitment to academic excellence, innovative research, and transformative global health solutions, aligning with the institution’s mission to advance the United Nations Sustainable Development Goal 3 (Good Health and Well-Being).
Professor Basile Njei: A Global Leader in Medicine and Research
Professor Basile Njei is an internationally acclaimed physician-scientist whose groundbreaking work in gastroenterology, hepatology, and epidemiology has redefined approaches to liver disease and digestive health. Holding advanced degrees in medicine (MD), public health (MPH), and epidemiology (PhD), Dr. Njei combines clinical expertise with rigorous research to address some of the most pressing challenges in global health.
At Yale School of Medicine, where he serves as a faculty member, Dr. Njei has pioneered the use of cutting-edge technologies, including AI and genetic sequencing, to enhance the diagnosis, treatment, and prevention of liver diseases such as hepatocellular carcinoma, non-alcoholic fatty liver disease (NAFLD), and viral hepatitis. His research leverages large-scale genomic datasets and machine learning algorithms to identify novel biomarkers and predict disease progression, offering personalized treatment pathways for patients worldwide.
Dr. Njei’s extensive publication record includes over 100 peer-reviewed articles in high-impact journals, such as The Lancet Gastroenterology & Hepatology and Hepatology. His studies on health disparities in liver disease outcomes have informed public health policies, particularly in low- and middle-income countries, where access to advanced diagnostics and treatments remains limited. Additionally, his global health initiatives, including collaborations with organizations like the World Health Organization (WHO), have advanced screening programs for hepatitis B and C in sub-Saharan Africa, contributing to SDG 3’s target of combating communicable diseases by 2030.
Strengthening EUCLID’s Academic and Research Mission
Professor Njei’s appointment significantly enhances EUCLID University’s academic offerings and research capabilities, particularly in its Master’s and Doctoral programs in Global Health and Bioethics. His expertise aligns seamlessly with EUCLID’s core values of Interfaith & Intercultural Skills and Sustainability is Reality, as he brings a multidisciplinary, inclusive approach to addressing global health challenges.
Contributions to Teaching and Mentorship
As a faculty member, Dr. Njei will develop and lead courses on advanced epidemiology, precision medicine, and AI applications in public health. His teaching philosophy emphasizes empowering students to bridge the gap between research and practice, equipping them with the tools to design evidence-based interventions for diverse populations. By incorporating case studies from his work in Africa, North America, and Europe, Dr. Njei will provide students with a global perspective on health disparities, fostering the intercultural competence central to EUCLID’s ethos.
Dr. Njei’s mentorship will be instrumental in guiding graduate students through complex research projects, particularly those leveraging AI and big data to address non-communicable diseases. His hands-on approach, honed through supervising medical residents and postdoctoral fellows at Yale, ensures that EUCLID students receive personalized support to excel in their academic and professional journeys.
Advancing Innovative Research
EUCLID’s commitment to innovative global health solutions is amplified by Dr. Njei’s research agenda. He will spearhead interdisciplinary projects exploring the intersection of genetics, AI, and social determinants of health, with a focus on liver disease prevention and management in resource-constrained settings. These projects will leverage EUCLID’s global network, including partnerships with governments and international organizations, to translate research into actionable policies.
One of Dr. Njei’s flagship initiatives at EUCLID will be the development of an AI-driven platform for early detection of liver cancer in underserved regions. By training machine learning models on anonymized patient data, this platform aims to identify high-risk individuals using low-cost biomarkers, reducing the burden of late-stage diagnoses. Such innovations align with SDG 3’s emphasis on universal health coverage and access to quality care, while also supporting SDG 10 (Reduced Inequalities) by prioritizing marginalized communities.
Enhancing EUCLID’s Global Impact
Dr. Njei’s appointment reinforces EUCLID’s role as a hub for global health leadership. His collaborations with African health ministries and international bodies will strengthen EUCLID’s capacity to influence health policy in the Global South. Furthermore, his expertise in health disparities complements EUCLID’s focus on sustainability, as he advocates for environmentally conscious healthcare practices, such as reducing the carbon footprint of medical diagnostics, in line with SDG 13 (Climate Action).
EUCLID’s Commitment to Excellence and Innovation
The addition of Professor Njei to EUCLID’s faculty reflects the university’s strategic vision of assembling world-class scholars to drive academic excellence and societal impact. His interdisciplinary approach, combining clinical medicine, public health, and cutting-edge technology, embodies EUCLID’s mission to prepare leaders who can navigate complex global challenges with innovation and empathy.
EUCLID’s School of Global Health and Bioethics, already recognized for its rigorous programs and contributions to SDG 3, is poised to reach new heights with Dr. Njei’s leadership. His work will enhance the university’s reputation as a pioneer in distance learning, offering flexible, high-quality education to students across 26 member states and beyond. By integrating AI and genetics into its curriculum, EUCLID ensures that its graduates are at the forefront of the global health revolution, equipped to address emerging threats like pandemics and climate-related diseases.
Alignment with Sustainable Development Goals
Dr. Njei’s contributions directly advance several SDGs:
- SDG 3 (Good Health and Well-Being): His research on liver disease and AI-driven diagnostics improves health outcomes and access to care, particularly in underserved regions.
- SDG 4 (Quality Education): His mentorship and course development empower students with cutting-edge knowledge, fostering lifelong learning.
- SDG 10 (Reduced Inequalities): His focus on health disparities addresses systemic inequities in healthcare access.
- SDG 17 (Partnerships for the Goals): His collaborations with global health organizations strengthen international cooperation.
By embedding these goals into his teaching and research, Dr. Njei exemplifies EUCLID’s holistic approach to education, where academic excellence serves as a catalyst for sustainable development.
The appointment of Professor Basile Njei, MD, MPH, PhD, marks a transformative moment for EUCLID University. His unparalleled expertise in digestive diseases, coupled with his innovative use of genetics and AI, positions him as a pivotal figure in advancing EUCLID’s mission of delivering world-class education and impactful research. As a faculty member, Dr. Njei will inspire students, drive groundbreaking discoveries, and strengthen EUCLID’s global influence in health policy and practice. His work not only elevates the university’s academic standing but also contributes to a healthier, more equitable world, in alignment with the SDGs. EUCLID proudly welcomes Professor Njei and looks forward to the profound impact he will have on its community and beyond.
Contact Information
For media inquiries or further information about Professor Njei’s appointment, please contact EUCLID’s Office of Communications at communications@euclid.int.
This post is also available in: French
